HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, July 2, 2021 (HealthDay News) -- Immediate sequential bilateral cataract surgery (ISBCS) is associated with worse visual outcomes compared with short-interval (one to 14 days between operations) delayed sequential bilateral cataract surgery (DSBCS-14) and long-interval (15 to 90 days) DSBCS (DSBCS-90), according to a study published online June 30 in JAMA Ophthalmology.
Julia P. Owen, Ph.D., from the University of Washington in Seattle, and colleagues compared refractive outcomes of 1,824,196 patients with bilateral visual acuity measurement who underwent bilateral surgery in a retrospective cohort study. Participants were categorized into three groups: ISBCS, DSBCS-14, and DSBCS-90.
The researchers found that after controlling for age, self-reported race, insurance status, history of age-related macular degeneration, diabetic retinopathy, and glaucoma, compared with the DSBCS-90 group, the uncorrected visual acuity (UCVA) of the first surgical eye was 0.41 letters higher and the best-corrected visual acuity (BCVA) was 0.89 letters higher in the DSBCS-14 group; the UCVA and BCVA were 2.79 and 1.64 letters lower, respectively, in the ISBCS group. For the second eye, the DSBCS-14 and ISBCS groups had UCVA and BCVA that were 0.79 and 0.48 letters higher and 1.67 and 1.88 letters lower, respectively, compared with the DSBCS-90 group.
"Unexpectedly, the DSBCS-14 group had similar but better visual acuity outcomes that were statistically significant compared with the DSBCS-90 group," the authors write.
One author disclosed financial ties to the pharmaceutical and medical device industries.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 24, 2022